Differences in Aβ brain networks in Alzheimer's disease and healthy controls

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2017
Source ID
10.1016/j.brainres.2016.11.019

Entities

People

  • Hucheng Zhou
  • Huoqiang Duan
  • Jiehui Jiang
  • Jun Xu
  • Zhemin Huang
  • Zhihua Yu
  • Zhuangzhi Yan

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • Ministry of Education of the People's Republic of China
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • National Natural Science Foundation of China
  • Northern California Institute for Research and Education
  • Pfizer
  • Roche (United States)
  • Shanghai Municipal Education Commission
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • University of California